Sun Pharma Q4 Results: Profit Down 19% Sequentially, Revenue Declines 6%
Sun Pharma reports Q4FY26 results with a 22% YoY increase in net profit to Rs 2,714 crore, despite a 19% sequential drop in PAT and 6% decline in revenue from Q3FY26. Annual performance shows 12.9% YoY revenue growth to Rs 58,220 crore.
